MX2012000957A - Solucion de gelatina adaptada y equilibrada al plasma. - Google Patents

Solucion de gelatina adaptada y equilibrada al plasma.

Info

Publication number
MX2012000957A
MX2012000957A MX2012000957A MX2012000957A MX2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A MX 2012000957 A MX2012000957 A MX 2012000957A
Authority
MX
Mexico
Prior art keywords
balanced
plasma
gelatin solution
pharmaceutical preparation
gelatin
Prior art date
Application number
MX2012000957A
Other languages
English (en)
Spanish (es)
Inventor
Michael Boll
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of MX2012000957A publication Critical patent/MX2012000957A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2012000957A 2009-07-20 2010-07-15 Solucion de gelatina adaptada y equilibrada al plasma. MX2012000957A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009034132A DE102009034132A1 (de) 2009-07-20 2009-07-20 Plasmaadaptierte und balancierte Gelatinelösung
PCT/EP2010/060210 WO2011009797A2 (fr) 2009-07-20 2010-07-15 Solution de gélatine équilibrée adaptée au plasma

Publications (1)

Publication Number Publication Date
MX2012000957A true MX2012000957A (es) 2012-03-06

Family

ID=43334706

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000957A MX2012000957A (es) 2009-07-20 2010-07-15 Solucion de gelatina adaptada y equilibrada al plasma.

Country Status (9)

Country Link
EP (1) EP2456446A2 (fr)
KR (1) KR20120046160A (fr)
CN (1) CN102470147A (fr)
BR (1) BR112012001229A2 (fr)
DE (2) DE102009034132A1 (fr)
IN (1) IN2012DN00419A (fr)
MX (1) MX2012000957A (fr)
RU (1) RU2012105925A (fr)
WO (1) WO2011009797A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
EP0223906A3 (fr) * 1982-10-29 1989-02-01 Synthetic Blood Corporation Sang entier synthétique à base de gélatine et son procédé de fabrication
EP1238675A1 (fr) 2001-03-06 2002-09-11 Fuji Photo Film B.V. Protéines recombinantes de type gélatine utilisées comme agents diluants du plasma

Also Published As

Publication number Publication date
CN102470147A (zh) 2012-05-23
WO2011009797A2 (fr) 2011-01-27
DE202010018349U1 (de) 2015-10-28
KR20120046160A (ko) 2012-05-09
WO2011009797A3 (fr) 2011-08-25
DE102009034132A1 (de) 2011-01-27
RU2012105925A (ru) 2013-08-27
IN2012DN00419A (fr) 2015-05-15
EP2456446A2 (fr) 2012-05-30
BR112012001229A2 (pt) 2016-03-01

Similar Documents

Publication Publication Date Title
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
WO2012088266A3 (fr) Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
IN2012DN02805A (fr)
IN2012DN03312A (fr)
MX2011008171A (es) Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma.
WO2011009759A3 (fr) Utilisation de dihydroquercétine et d'au moins un acide aminé pour influencer positivement le processus de pigmentation naturel
MX348823B (es) Formulaciones estables de linaclotida.
HN2010002518A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
MX342947B (es) Tratamiento de diabetes tipo 2.
DOP2011000245A (es) Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapeutica
WO2012049307A3 (fr) Nouveaux dérivés d'insuline à extrémité n modifiée
MX2013002948A (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
WO2011106417A3 (fr) Formulations à base de garcinia mangostana l. et d'iridoïdes
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
MX2012000954A (es) Composicion far,aceutica topica que incuye la rel-n-[6-[(2r,6s)-2,6-dimetil-4-morfolinil]-3-piridinil]-2-metil- 4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
CR20110701A (es) Derivados de pirazoles, su preparacion y su aplicacion terapeutica.
MX2013001793A (es) Producto para la esfera gastrica superior.
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
WO2011107866A3 (fr) Dérivés silyliques de polysaccharides
MX2012000957A (es) Solucion de gelatina adaptada y equilibrada al plasma.
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина

Legal Events

Date Code Title Description
FA Abandonment or withdrawal